Evidence map›Paper›PMID 39874103›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2025

Performance of Creatinine and Cystatin-Based Equations on Estimating Measured GFR in People with Hematological and Solid Cancers.

Silvia M Titan, John C Lieske, Jeffrey W Meeusen, Stacy Thorson, Yi Lin, Grzegorz S Nowakowski, Jason N Barreto, Erin F Barreto, Kathryn J Ruddy, Nelson Leung and 2 more

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Ten tips for an onco-nephrology clinic.Clinical kidney journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Silvia M TitanNephrology and Hypertension Division, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-6206-1111
John C LieskeNephrology and Hypertension Division, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-0202-5944
Jeffrey W MeeusenNephrology and Hypertension Division, Mayo Clinic, Rochester, Minnesota.
Stacy ThorsonBiomedical Informatics, Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0006-1198-6786
Yi LinHematology Division, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-1556-6416
Grzegorz S NowakowskiHematology Division, Mayo Clinic, Rochester, Minnesota.
Jason N BarretoDepartment of Pharmacy, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-2146-5766
Erin F BarretoDepartment of Pharmacy, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-0996-1487
Kathryn J RuddyMedical Oncology Division, Mayo Clinic, Rochester, Minnesota.
Nelson LeungNephrology and Hypertension Division, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-5651-1411
Andrew D RuleNephrology and Hypertension Division, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-0338-7784
Sandra M HerrmannNephrology and Hypertension Division, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-3700-4537

Funding

Beta-lactam individualization for critically ill patientsK23AI143882 · NIAID · MAYO CLINIC ROCHESTER · PI BARRETO, ERIN FRAZEE · 2020 to 2024
$986k
Mayo Clinic 95070002NIAID NIH HHS K23 AI143882
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39874103
PMCPMC11905996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.